Sort
53,477 grants matching “addiction”
Neural systems mediating the extinction and inhibition of cocaine seeking
$442,921Ryan T Lalumiere · University Of Iowa · R01 · FY2022 · DA
Neural systems mediating the extinction and inhibition of cocaine seeking
$442,921Ryan T Lalumiere · University Of Iowa · R01 · FY2024 · DA
Neural systems mediating the extinction and inhibition of cocaine seeking
$442,921Ryan T Lalumiere · University Of Iowa · R01 · FY2023 · DA
Neural systems mediating the extinction and inhibition of cocaine seeking
$442,921Ryan T Lalumiere · University Of Iowa · R01 · FY2021 · DA
Synaptic actin dynamics and the selective vulnerability of drug-associated memory
$442,914Courtney A Miller · Scripps Florida · R01 · FY2016 · DA
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
$442,914Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA
Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders
$442,914Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
$442,908Namasivayam Ambalavanan · University Of Alabama At Birmingham · UG1 · FY2021 · HD
Studies in Cocaine Abuse
$442,902Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2003 · DA
Dynorphin /kappa mesolimbic system in heroin abuse
$442,849Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2006 · DA
Machine learning discovery of patterns of self regulation in drug addiction and I
$442,820Rita Z Goldstein · Icahn School Of Medicine At Mount Sinai · R21 · FY2012 · DA
Cellular and molecular analysis of startle modulation
$442,812Michael Granato · University Of Pennsylvania · R01 · FY2019 · MH
Neuropeptide Y Y1 Receptor Imaging Agents for Positron Emission Tomography
$442,810Neale S Mason · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AA
Spatial inference methods for image analysis
$442,809Armin Schwartzman · University Of California, San Diego · R01 · FY2019 · EB
Stress and Drug Use Vulnerability in the African American Community
$442,781Ezemenari M Obasi · University Of Houston · R01 · FY2013 · DA
Risk of Care Escalation after Non-Pharmacologic Treatment: Leveraging Real World Physical Therapy Data
$442,750Trevor Lentz · Duke University · R21 · FY2022 · AR
Bifunctional Antibodies for Melanoma Therapy
$442,736Peter M Glazer · Yale University · R01 · FY2016 · CA
Bifunctional Antibodies for Melanoma Therapy
$442,736Peter M Glazer · Yale University · R01 · FY2015 · CA
Cocaine-induced neuroplasticity: a new role for TGF beta signaling
$442,663David M Dietz · State University Of New York At Buffalo · R01 · FY2017 · DA
Dopamine Transporter Cell Surface Dynamics
$442,642Haley E Melikian · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · DA
Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine
$442,625Sergii Dvoriak · Ukrainian Institute On Public Health Policy · R01 · FY2021 · DA
3/6 COMpAAAS U01: Intervention Study
$442,552David Fiellin · Yale University · U01 · FY2020 · AA
Targeting of alpha7 nAChR for therapeutic effects
$442,527Roger L Papke · University Of Florida · R01 · FY2011 · GM
Human Laboratory Screening of Pregabalin and Tiagabine for Cannabis Dependence
$442,520Joshua Anthony Lile · University Of Kentucky · R01 · FY2017 · DA
Role of Extended Amygdala in Opiate and Cocaine Abuse
$442,500Gary S. Aston-Jones · Medical University Of South Carolina · R37 · FY2009 · DA